Skip to main content
OpenTrials
Completed

NCT Number: NCT01091753

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

The purpose of this study is to determine the effect of nocturnal administration of Anti-hypertensive medications in Non-dippers.

Efficacy variables.

1. ECHO 2. 24hr. horter 3. IMT 4. BUN/crea, urine analysis (microalbulinuria 5. Cardio vascular event. "

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Severance Hospital, Yonsei University College of Medicine

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Essential hypertension (stage 1-2)
  • 24hr. holer : non-dipper
  • Age 18 ~70.

Exclusion criteria

  • Any known malignant disease
  • Renal failure , creatinine >2.0mg/dl
  • Liver disease

Treatment and study plan

Valsaltan, amlodipine

Drug

nti hypertensive medication time (nocturnal administration vs morning administration

Primary outcomes

  1. IMT(intima media thickness) Measure data(Sono)

    Time frame: baseline

  2. IMT(intima media thickness) Measure data(Sono)

    Time frame: 36 months

Sponsors and collaborators

Lead sponsor

Yonsei University

Other

Registry information

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Mar 24, 2010
Registry last updated
Oct 8, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.